Peribronchial Inflammation Resulting from Regulatory T Cell Deficiency Damages the Respiratory Epithelium and Disturbs Barrier Function

Regulatory T cells (Tregs) that express the transcription factor Foxp3 have a critical role in limiting inflammatory processes and tissue damage. Whether Tregs are functional in maintaining epithelial barriers and in control of tight junction expression has not yet been explored. In this study, we investigated the effect of Treg deficiency on the airway epithelial barrier in an experimental murine model in which diphtheria toxin was repeatedly injected in Foxp3-diphtheria toxin receptor (DTR) mice to deplete Tregs. This resulted in spontaneous peribronchial inflammation and led to a systemic and local increase of IL-4, IL-5, CCL3, IFN-γ, and IL-10 and a local (lung) increase of IL-6 and IL-33 and decreased amphiregulin levels. Moreover, Treg depletion increased airway permeability and decreased epithelial tight junction (protein and mRNA) expression. CTLA4-Ig treatment of Treg-depleted mice almost completely prevented barrier dysfunction together with suppression of lung inflammation and cytokine secretion. Treatment with anti–IL-4 partly reversed the effects of Treg depletion on tight junction expression, whereas neutralization of IL-6 of IFN-γ had either no effect or only a limited effect. We conclude that Tregs are essential to protect the epithelial barrier at the level of tight junctions by restricting spontaneous T cell activation and uncontrolled secretion of cytokines, in particular IL-4, in the bronchi. Key Points Tregs are important in maintaining epithelial barrier function. Treg depletion increases lung IL-33 and IL-4, contributing to a disrupted epithelium.

[1]  S. Seys,et al.  Innate Lymphoid Cells Are Required to Induce Airway Hyperreactivity in a Murine Neutrophilic Asthma Model , 2022, Frontiers in Immunology.

[2]  C. Akdis Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? , 2021, Nature Reviews Immunology.

[3]  R. Hewitt,et al.  Regulation of immune responses by the airway epithelial cell landscape , 2021, Nature Reviews Immunology.

[4]  C. Neumann,et al.  The Many Functions of Foxp3+ Regulatory T Cells in the Intestine , 2020, Frontiers in Immunology.

[5]  Josalyn L Cho,et al.  Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung , 2020, Nature Immunology.

[6]  P. Hellings,et al.  Epithelial barriers in allergy and asthma , 2020, Journal of Allergy and Clinical Immunology.

[7]  K. Kabashima,et al.  Tight junctions in the development of asthma, chronic rhinosinusitis, atopic dermatitis, eosinophilic esophagitis, and inflammatory bowel diseases , 2020, Journal of leukocyte biology.

[8]  S. Sakaguchi,et al.  Regulatory T Cells and Human Disease. , 2020, Annual review of immunology.

[9]  P. Hellings,et al.  Nasal epithelial barrier dysfunction increases sensitization and mast cell degranulation in the absence of allergic inflammation , 2019, Allergy.

[10]  S. Ziegler,et al.  Epithelial cell–derived cytokines: more than just signaling the alarm , 2019, The Journal of clinical investigation.

[11]  F. Powrie,et al.  Regulatory T cell adaptation in the intestine and skin , 2019, Nature Immunology.

[12]  L. Tam,et al.  IL33: Roles in Allergic Inflammation and Therapeutic Perspectives , 2019, Front. Immunol..

[13]  M. Si-Tahar,et al.  Inactivation of the interleukin‐22 pathway in the airways of cystic fibrosis patients , 2019, Cytokine.

[14]  H. Nakajima,et al.  Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation , 2018, Front. Immunol..

[15]  P. Hellings,et al.  Histamine and T helper cytokine–driven epithelial barrier dysfunction in allergic rhinitis , 2017, The Journal of allergy and clinical immunology.

[16]  J. Mock,et al.  Foxp3+ Regulatory T Cell Expression of Keratinocyte Growth Factor Enhances Lung Epithelial Proliferation , 2017, American journal of respiratory cell and molecular biology.

[17]  S. Seys,et al.  IL-13 is a central mediator of chemical-induced airway hyperreactivity in mice , 2017, PloS one.

[18]  H. Kita,et al.  IL‐33: biological properties, functions, and roles in airway disease , 2017, Immunological reviews.

[19]  S. Seys,et al.  Forced expiration measurements in mouse models of obstructive and restrictive lung diseases , 2017, Respiratory Research.

[20]  J. Fahy,et al.  Claudin‐18 deficiency is associated with airway epithelial barrier dysfunction and asthma , 2017, The Journal of allergy and clinical immunology.

[21]  M. Balda,et al.  Tight junctions: from simple barriers to multifunctional molecular gates , 2016, Nature Reviews Molecular Cell Biology.

[22]  P. Hellings,et al.  Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression. , 2016, The Journal of allergy and clinical immunology.

[23]  A. Rudensky,et al.  A Distinct Function of Regulatory T Cells in Tissue Protection , 2015, Cell.

[24]  R. Locksley,et al.  Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation. , 2015, Immunity.

[25]  W. Gause,et al.  Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. , 2015, Immunity.

[26]  W. Mitzner,et al.  Foxp3+ Regulatory T Cells Promote Lung Epithelial Proliferation , 2014, Mucosal Immunology.

[27]  D. Ye,et al.  Interleukin-6 Modulation of Intestinal Epithelial Tight Junction Permeability Is Mediated by JNK Pathway Activation of Claudin-2 Gene , 2014, PloS one.

[28]  S. Georas,et al.  Interleukin-4 and interleukin-13 cause barrier dysfunction in human airway epithelial cells , 2013, Tissue barriers.

[29]  C. Akdis,et al.  Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4. , 2012, The Journal of allergy and clinical immunology.

[30]  L. Petecchia,et al.  Cytokines induce tight junction disassembly in airway cells via an EGFR-dependent MAPK/ERK1/2-pathway , 2012, Laboratory Investigation.

[31]  P. Howarth,et al.  Defective epithelial barrier function in asthma. , 2011, The Journal of allergy and clinical immunology.

[32]  A. Rudensky,et al.  Cutting Edge: Depletion of Foxp3+ Cells Leads to Induction of Autoimmunity by Specific Ablation of Regulatory T Cells in Genetically Targeted Mice1 , 2009, The Journal of Immunology.

[33]  S. Dahlén,et al.  Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice , 2009, European Respiratory Journal.

[34]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[35]  A. Fischer,et al.  Hematoxylin and eosin staining of tissue and cell sections. , 2008, CSH protocols.

[36]  A. Sharpe,et al.  Induction of autoimmune disease in CTLA-4−/− mice depends on a specific CD28 motif that is required for in vivo costimulation , 2007, Proceedings of the National Academy of Sciences.

[37]  A. Rudensky,et al.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice , 2007, Nature Immunology.

[38]  R. Valenta,et al.  IFN-γ–enhanced allergen penetration across respiratory epithelium augments allergic inflammation , 2005 .

[39]  D. Teitelbaum,et al.  Interleukin-6 changes tight junction permeability and intracellular phospholipid content in a human enterocyte cell culture model , 2003, Pediatric Surgery International.

[40]  B. Decallonne,et al.  An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. , 2001, Methods.

[41]  D. Galas,et al.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.

[42]  V. Brusasco,et al.  Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. , 1998, American journal of respiratory and critical care medicine.